PRE 14A

PRE 14A Filing

Company: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Filed: September 29, 2023
Period of Report: September 29, 2023
Accession Number: 0001493152-23-034839

View Document ↗ View on SEC.gov ↗